SR Pillemer, J Smith, PC Fox, SJ Bowman - The Journal of …, 2005 - jrheum.org
The goal of the Outcome Measures for Sjögren's Syndrome Workshop was to develop consensus on a core set of outcome measures for clinical trials in Sjögren's syndrome (SS) …
FB Vivino, SE Carsons, G Foulks… - Rheumatic …, 2016 - rheumatic.theclinics.com
Among all the chronic autoimmune rheumatic disorders, Sjogren's disease (SD) is among the most difficult to evaluate and manage. Clinicians are frequently challenged to …
R Seror, E Theander, H Bootsma, SJ Bowman… - Journal of …, 2014 - Elsevier
Lymphocytic infiltration of different exocrine and non-exocrine epithelia is the pathological hallmark of primary Sjögren's syndrome, whereas involvement of salivary and lachrymal …
G Nocturne, X Mariette - Arthritis & Rheumatology, 2023 - Wiley Online Library
The management of Sjögren's disease is challenging because of several factors. Indeed, the clinical presentations are heterogeneous, and one must be able to identify prognostic …
R Seror, X Mariette - Rheumatology, 2017 - academic.oup.com
Guidelines can be defined as recommendations on the optimal way to manage and treat patients with one condition. Establishing guidelines is a huge, difficult and timeconsuming …
LL Marshall, GA Stevens - The Consultant Pharmacist®, 2018 - ingentaconnect.com
Management of Primary Sjögren's Syndrome Page 1 Clinical Review Management of Primary Sjögren’s Syndrome Leisa L. Marshall, Gregg A. Stevens OBJECTIVE: Review the clinical …
Introduction Despite ongoing efforts to develop effective therapeutics, no disease-modifying drugs have been officially licensed for the indication of Sjögren's disease (SjD). This is partly …
The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in recent decades: treatment decisions remain challenging in clinical practice, without a …
SE Carsons - Rheumatic Disease Clinics of North America, 2008 - Elsevier
Published studies and trials of oral and biologic disease-modifying antirheumatic drugs for the treatment of Sjögren's syndrome have shown disappointing results. Improvements in trial …